The accurate diagnosis and seroprevalence investigations of Zika virus (ZKV) infections remain 21 complex due to cross reactivity with other flaviviruses. Two assay formats, both using labelled Zika 22 virus NS1 antigen as a revealing agent (a double antigen binding assay, DABA, and an 23 immunoglobulin Ig capture assay, IgG capture) were initially developed and compared with the 24 indirect EuroimmunZ assay for the detection of anti-Zika antibody. Of 147 pre-Zika period serum 25 samples, 39 (27%) were reactive in the EuroimmunZ or the DABA assays, 28 sera concordantly 26 so. Such false reactivity was influenced by the serotype of Dengue virus (DV) to which individuals 27 had been exposed to. Thus, of sera from patients undergoing secondary Dengue virus infection of 28 known serotype, 91%, 45% and 28% of Dengue virus serotype 2, 3 and 4 respectively were reactive 29 in one or more of the three assays. A novel method of quenching false sero-reactivity was therefore 30 developed for the DABA and IgG capture assays. Initial addition of a single homologous Dengue 31 virus serotype 3 NS1Ag quench significantly ablated false reactivities in the pre-Zika period sera. 32 An equipotent quadrivalent quench comprising homologous Dengue virus serotypes 1 to 4 NS1Ag
Introduction

44
Zika virus (ZKV), first described in a nonhuman primate in 1947, is named after a forested area in 45 Uganda [1] . Its ability to infect humans was first demonstrated in 1952 as reviewed by Kindhauser 46 and colleagues [2] with antibody to ZKV detected both by neutralisation and by animal protection experiments [3] . Zika virus is one of a number of closely related Flaviviruses, previously termed 48 Arboviruses, principally transmitted through the bite of an infected Aedes mosquito, most commonly
49
Aedes aegypti but which may also be transmitted directly between humans through sexual contact 50 or vertically, from mother to the unborn baby. Although possible, no cases of transmission through 51 transplantation of cells, tissues or organs have been reported to date; probable transmission 52 through blood products have been reported [4] [5] [6] .
53
Similar to other related flaviruses, ZKV infection is believed to be asymptomatic in up to 80% of 54 cases, with a minority manifesting often mild symptomatology [7] . The clinical illness is of short 
58
It is likely that ZKV may have caused outbreaks of disease but that these may well have been 59 unrecognised because the clinical illness is similar to that caused by other known pathogens 60 including Dengue (DV) and Chikungunya viruses. Where ZKV differs is that its neuro-tropism and 61 ability to infect the unborn child transplacentally leads to serious neurological birth defects [11] . The 62 significant morbidity caused by Congenital Zika Syndrome, the societal impact and costs of this in 63 both Polynesia and more recently in countries in South and Central America have added to the 64 requirement for both sensitive and specific tests for the detection of antibody to ZKV (anti-ZKV).
65
However, extensive serological cross-reactivity between flaviviruses and their co-circulation has 66 rendered this difficult to achieve using the conventional indirect immunoassay format. 
151
Conjugation of rZKVNS1Ag
152
One hundred microlitres of recombinant ZIKV NS1 antigen (ensuring at an optimal protein 153 concentration range of 0.5-5.0mg/ml) were coupled to 100µg of lyophilized HRPO mix using the the different quenching rDVNS1Ags was greatly influenced by the rDVNS1Ag serotype (Table 1) .
252
We also investigated quenching as a quadrivalent equipotent rNS1Ag-blend of all 4 serotypes at 253 concentrations from 25, 12.5 to 6.25μg/ml. To explore further the quenching effect of using conjugate blocked with the optimised quadrivalent 286 mixture of rDVNS1Ag, 87 samples from the 2014 outpatient cohort were retested using quadrivalent 287 blocked conjugate at 6.25ug/ml. Twenty three samples reactive in the unblocked DABA and 27 288 reactive in EuroimmunZ were all unreactive in the quadrivalent blocked DABA (Figures 4a and 4b) . 
318
By the early part of 2016, the WHO declared that ZKV infection, associated as it was with severe 319 neurological disorders in the new-born, was a public health emergency of international concern. A 320 particular aspect arising from this decision was the requirement for specific and sensitive serological 321 assays for the detection of anti-ZKV antibody. This was always going to be challenging because of 322 the potential exposure to multiple co-circulating Flavi-viruses in endemic areas, with the known 323 potential to elicit serological cross reactivity between these infections. 
327
Recognising that antibody to envelope proteins is often cross-reactive within subgroups of the Flavi-328 viridae family, Stettler and her colleagues [14] moved to use the non-structural protein NS1 in view 329 of data suggesting that this protein was likely to provide a more species-specific antigen moiety for 330 use as the solid phase in immunoassays. A similar conceptual approach is employed in the 331 benchmark and widely used EuroimmunZ assay which uses rZKVNS1Ag in an indirect assay 332 format. These observations informed our choice of the NS1 target and our decision to explore assay 333 formats other than the indirect immunoassay.
334
It is clear however that the use of the NS1 protein in the EuroimmunZ indirect immunoassay format 335 is still associated with significant cross-reactivity likely to be generated by prior Flavi-virus co-336 circulation and repeated exposure in the community prior to the introduction of ZKV into new 337 geographical areas (Figure 1) . In examining the different assay formats of IgG capture and DABA 338 we find a similar lack of high specificity from patient and blood donor samples collected in two 339 different areas of South East Brazil before the introduction of ZKV into the Americas.
340
The comparative sensitivity of the three assay formats was examined using 91 samples from 341 patients sampled at different times after the onset of disease symptoms (figure 2) using unblocked 342 conjugates in the IgG capture and DABA formats. In overall ranking it is likely that the DABA format,
343
in essence a total antibody test, was marginally more proficient at detecting early and late 344 serological markers than the other two formats. The DABA format will recognise antibody of any Figure 3 ). In many cases there was concordant reduction in both assay formats.
354
Our data showed that extinguishing cross reactivity was best achieved by using an equipotent four 355 component mix of rDVNS1Ags (Table 1) shown and the overall reactivity for each assay displayed.
467 Figure 3 . X by Y plots of sample reactivity from patients known to have been infected with ZKV.
468
Reactivity is expressed as sample to cut off ratios when tested using un-blocked conjugate and 
